Section Arrow
NVCT.NASDAQ
- Nuvectis Pharma
Quotes are at least 15-min delayed:2026/09/20 03:15 EDT
Regular Hours
Last
 22
+0.62 (+2.90%)
Day High 
23 
Prev. Close
21.38 
1-M High
25.9399 
Volume 
880.12K 
Bid
21.6
Ask
22.5
Day Low
21.06 
Open
21.27 
1-M Low
19.06 
Market Cap 
697.93M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 23.06 
20-SMA 23.55 
50-SMA 21.21 
52-W High 29.275 
52-W Low 5.55 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.32/-0.95
Enterprise Value
697.93M
Balance Sheet
Book Value Per Share
0.28
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
RXRXRecursion Pharmaceuticals3.83+0.29+8.19%-- 
TCRTAlaunos Therapeutics Inc.1.2-0.4-25.00%-- 
ROIVRoivant Sciences Ltd39.77-0.21-0.53%-- 
SLXNSilexion Therapeutics Corp.0.4355+0.0555+14.61%-- 
IOVAIovance Biotherapeutics10.25+0.23+2.30%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.